Navigation Links
Senetek PLC Launches Dedicated Pyratine-6(TM) Website
Date:1/27/2009

NAPA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today the launch of a dedicated Pyratine-6(TM) website, http://www.Pyratine-6.com, that provides information to consumers and medical professionals about Pyratine-6, Senetek's advanced cytokinin technology.

The website (http://www.Pyratine-6.com) is a comprehensive and convenient resource for information on Senetek's anti-aging cytokinin technology and the Pyratine-6(TM) product line, which includes Pyratine-6(TM) Lotion, Creme, Foaming Cleanser, Soft Creme + 10% Vitamin C. An SPF product will be introduced in Spring 2009 to complete the Pyratine-6(TM) line.

Detailed sections provide site visitors with a scientific analysis of cytokinins for therapeutic applications, and present the results of a 12-week independent clinical trial that demonstrates the efficacy of Pyratine-6(TM) for roughness, erythema, hyperpigmentation, skin moisture, and fine wrinkles. Also featured is Senetek's history in the development of innovative skincare technologies, including the cytokinins Kinetin and Zeatin. Additionally, a dedicated physician-only section will soon provide local resources, staff training tools and sales support to the medical community.

"The launch of the Pyratine-6(TM) website allows both consumers and physicians practical, reliable access to cutting-edge anti-aging information and products from Senetek," said Frank Massino, CEO of Senetek PLC. "The straightforward design of the site echoes and supports our research-based, results-driven technology."

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
2. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
3. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
4. Isogen Launches Major New Facility to Address Global Biopharma Demand
5. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
6. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
7. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
8. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
9. Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
10. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2017)... , May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: ... Inc. ("WRB"), a health care service center company ... WRB specializes in relationship management programs for leading ... WRB will join Envoy ... support services for manufacturers, biotech firms, and other service ...
(Date:5/6/2017)... CHICAGO , May 5, 2017  May is ... of one of the most important methods to prevent ... to the Centers for Disease Control and Prevention, undetected ... stroke. 1 Omron, the global leader in personal ... on the elimination of heart attack and stroke and ...
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" ... to be the first to eliminate the need for embryonic ... cells to treat neurodegenerative diseases. Fortuna ... with Professor Michael Fehlings , MD, PhD; Father ... , MD, MPH; and Professor James Giordano , PhD. ...
Breaking Medicine Technology:
(Date:5/22/2017)... ... ... Today, Our Urgent Care celebrates the grand opening of its newest urgent ... opening over a month ago, Our Urgent Care Washington has enjoyed serving Franklin County ... Care walk-in clinic is located at 3195 Phoenix Center Dr., Washington, MO 63090 in ...
(Date:5/22/2017)... ... 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” tells the story in ... Rodriguez takes readers on a rollercoaster ride that includes a midnight trek to the ... a dark place where Donald considers suicide. Readers learn how Donald finally achieves ...
(Date:5/22/2017)... , ... May 22, 2017 , ... Faithfully following pop ... body squatted, stretched, jumped, toned and shaped through fitness programs. It carries on to ... course, finished off with an irresistible, radiant smile. CDA has found that ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... a larger group investing in InsightRX, an early stage company in San Francisco ... and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as the lead ...
(Date:5/21/2017)... Texas (PRWEB) , ... May 19, 2017 , ... ... is pleased to announce the appointment of James (Jim) Vertino as Chief Information ... is a proven, transformational leader who drives innovation and business performance. He defines ...
Breaking Medicine News(10 mins):